Last reviewed · How we verify
NCT03337763
A Prospective Pilot Study (BIO|SELECT Pilot)
trial in Heart Failure in 201 participants. Completed in 7 October 2019.
7 October 2019
Quick facts
| Lead sponsor | Biotronik SE & Co. KG |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 201 |
| Start date | 7 November 2017 |
| Primary completion | 7 October 2019 |
| Estimated completion | 7 October 2019 |
| Sites | 1 location across Japan |
Conditions studied
- Heart Failure — all drugs for Heart Failure →
Sponsor
Biotronik SE & Co. KG — full company profile →
Who can join
20 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Enrolled patients implanted with Biotronik CRT-D and QP lead equipped with MultiPole pacing mode is grouped into which programmed into MultiPole pacing, or conventional bi-ventricular pacing mode. They are followed up by seven month post implantation, and predefined cardiac functional parameters are collected at each visit.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intracardiac conduction time as a predictor of cardiac resynchronization therapy response: Results of the BIO|SELECT pilot study.
Soejima K, Kondo Y, Sasaki S, Adachi K, et al · · 2021 · cited 4× · PMID 34988503 · DOI 10.1016/j.hroo.2021.09.007
Verify or expand the search:
- PubMed search for NCT03337763
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other Biotronik SE & Co. KG trials
Trials by the same sponsor.
- NCT07393009 — Studying Routine Patient Care With BIOTRONIK Devices That Allow a More Natural Heart Stimulation · not yet recruiting
- NCT06989580 — BIO|CONCEPT.BIOMONITOR-HF Collect Clinical Data From Heart Failure Patients Using BIOMONITOR Devices With a Study Specif · NA · recruiting
- NCT06018818 — Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family · NA · completed
- NCT05426785 — To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP) · NA · recruiting
- NCT05761249 — BIOSTREAM.HF HeartInsight · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03337763 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biotronik SE & Co. KG
- Last refreshed: 27 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03337763.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing